Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Steger

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 30, 2009
Neoadjuvant chemoradiation with paclitaxel/carboplatin for selected Stage III non-small-cell lung cancer: long-term results of a trimodality Phase II protocolThomas Hehr, Godehard Friedel, Volker Steger, et al.
Radiology Research and Practice|February 13, 2013
Safety and Efficacy of the Prostar XL Vascular Closing Device for Percutaneous Closure of Large Arterial Access SitesChristoph Thomas, Volker Steger, Stefan Heller, et al.
The Annals of Thoracic Surgery|May 26, 2009
Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survivalVolker Steger, Thorsten Walles, Bora Kosan, et al.
The Annals of Thoracic Surgery|May 29, 2007
Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodesesVolker Steger, Ute Mika, Heikki Toomes, et al.
Updates in Surgery|August 21, 2022
Thoracoscopic mesh implantation as a definitive treatment approach for peritoneal dialysis-associated hydrothoraxAttila Nemeth, Migdat Mustafi, Godehard Friedel, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 12, 2012
Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer?Volker Steger, Werner Spengler, Jürgen Hetzel, et al.
Interactive Cardiovascular and Thoracic Surgery|September 22, 2012
Surgery on unfavourable persistent N2/N3 non-small-cell lung cancer after trimodal therapy: do the results justify the risk?Volker Steger, Tobias Walker, Migdat Mustafi, et al.
Deutsche Medizinische Wochenschrift (1946)|March 23, 2026
[Non-small cell lung cancer - surgical treatment options in the early stages]Attila Nemeth, Godehard Friedel, Thorben Groß, et al.
Deutsche Medizinische Wochenschrift (1946)|September 7, 2016
[A rare cause of pulmonary embolism]Hui Jing Qiu, Roderich Rietig, Volker Steger, et al.
Interactive Cardiovascular and Thoracic Surgery|July 4, 2012
Postoperative chest tube management: snapshot of German diversityAlbert Linder, Clemens Ertner, Volker Steger, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Radiation Oncology, Biology, Physics|October 30, 2009
Neoadjuvant chemoradiation with paclitaxel/carboplatin for selected Stage III non-small-cell lung cancer: long-term results of a trimodality Phase II protocolThomas Hehr, Godehard Friedel, Volker Steger, et al.
Radiology Research and Practice|February 13, 2013
Safety and Efficacy of the Prostar XL Vascular Closing Device for Percutaneous Closure of Large Arterial Access SitesChristoph Thomas, Volker Steger, Stefan Heller, et al.
The Annals of Thoracic Surgery|May 26, 2009
Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survivalVolker Steger, Thorsten Walles, Bora Kosan, et al.
The Annals of Thoracic Surgery|May 29, 2007
Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodesesVolker Steger, Ute Mika, Heikki Toomes, et al.
Updates in Surgery|August 21, 2022
Thoracoscopic mesh implantation as a definitive treatment approach for peritoneal dialysis-associated hydrothoraxAttila Nemeth, Migdat Mustafi, Godehard Friedel, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 12, 2012
Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer?Volker Steger, Werner Spengler, Jürgen Hetzel, et al.
Interactive Cardiovascular and Thoracic Surgery|September 22, 2012
Surgery on unfavourable persistent N2/N3 non-small-cell lung cancer after trimodal therapy: do the results justify the risk?Volker Steger, Tobias Walker, Migdat Mustafi, et al.
Deutsche Medizinische Wochenschrift (1946)|March 23, 2026
[Non-small cell lung cancer - surgical treatment options in the early stages]Attila Nemeth, Godehard Friedel, Thorben Groß, et al.
Deutsche Medizinische Wochenschrift (1946)|September 7, 2016
[A rare cause of pulmonary embolism]Hui Jing Qiu, Roderich Rietig, Volker Steger, et al.
Interactive Cardiovascular and Thoracic Surgery|July 4, 2012
Postoperative chest tube management: snapshot of German diversityAlbert Linder, Clemens Ertner, Volker Steger, et al.
Pageof 5